Oncology Pharma Inc.
ONPH · OTC
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $113 | $297 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $114 | $297 | $3 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$15 | -$0 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$105 | -$97 | -$0 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.42 | -6.76 | -0.12 | -0.72 |
| % Growth | 49.4% | -5,533.3% | 83.3% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |